Non-Myeloablative Allogeneic Transplantation with Post-Transplant Cyclophosphamide after Immune Checkpoint Inhibition for Classic Hodgkin Lymphoma: a Retrospective Cohort Study

BACKGROUND: Immune checkpoint inhibitors (ICIs) are approved in relapsed classic Hodgkin lymphoma (cHL). The safety and effectiveness of allogeneic blood or marrow transplantation (alloBMT) in ICI pretreated cHL patients remain unclear. The aim of this study is to assess outcomes of cHL patients rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Biol Blood Marrow Transplant
Main Authors: Paul, Suman, Zahurak, Marianna, Luznik, Leo, Ambinder, Richard F., Fuchs, Ephraim J., Bolaños-Meade, Javier, Wagner-Johnston, Nina, Swinnen, Lode J., Schoch, Laura, Varadhan, Ravi, Jones, Richard J., Gladstone, Douglas E.
Formato: Artigo
Idioma:Inglês
Publicado em: 2020
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7486273/
https://ncbi.nlm.nih.gov/pubmed/32592857
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bbmt.2020.06.012
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados